Learn More
Medchemexpress LLC Enbezotinib | 2359649-81-1 | 99.5% | C21H21FN6O3 | 100 MG

Supplier: Medchemexpress LLC HY145565100MG
Enbezotinib, also known as TPX-0046, is an inhibitor of RET that can inhibit RET autophosphorylation and is utilized for cancer research.
- Inhibits p-RET (y905) in RET-driven cells at concentrations of 0.3-300 nM in vitro
- Decreases tumor size in mice when administered at 2-5 mg/kg, twice daily for 27 days in vivo
- Molecular weight: 424.43
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.